HHS Recovery Act Recipient Reporting Readiness Tool
Step 3. Select A Grant Award
Review the list of awards and select the Award Title link to see the required reporting data.
| DUNS Number | Award Number | Award Title | Agency | Fiscal Year | Issue Date | Funding Amount |
| 071723621 | 1C06RR028581-01 | A MINI-CYCLOTRON FACILITY TO SUPPORT CANCER RESEARCH AT THE BIDMC/HMS | NIH | 2010 | 03-04-2010 | $ 1,793,470 |
| 071723621 | 1F32AI081513-01 | TETRASPANINS IN ASTHMA AND EOSINOPHILIC LUNG DISEASE | NIH | 2009 | 07-14-2009 | $ 59,402 |
| 071723621 | 1F32AI084373-01 | ROLE OF INTERLEUKIN 21 IN THE ALLOGRAFT RESPONSE | NIH | 2009 | 08-28-2009 | $ 51,710 |
| 071723621 | 1R01AG028076-01A2 | CEREBROMICROVASCULAR DISEASE IN ELDERLY WITH DIABETES | NIH | 2009 | 08-12-2009 | $ 609,162 |
| 071723621 | 1R01AI072287-01A2 | AUTOCRINE CONTROL OF NEUTROPHIL CHEMOTAXIS | NIH | 2009 | 05-12-2009 | $ 383,000 |
| 071723621 | 1R01AI075129-01A2 | STORE OPERATED CALCIUM INFLUX IN CELLS OF THE IMMUNE SYSTEM | NIH | 2009 | 06-17-2009 | $ 425,000 |
| 071723621 | 1R01CA130895-01A2 | INHIBITION OF ANGIOGENESIS BY THROMBOSPONDIN-1 (A2) | NIH | 2009 | 06-17-2009 | $ 371,633 |
| 071723621 | 1R01CA142262-01 | VEGFS IN TUMOR LYMPHATIC METASTASIS | NIH | 2009 | 07-14-2009 | $ 459,337 |
| 071723621 | 1R01GM088184-01 | ROLE OF VEGF AND PLGF SIGNALING IN SEPSIS | NIH | 2009 | 09-07-2009 | $ 374,130 |
| 071723621 | 1R01HL091874-01A1 | ENDOTHELIAL DYSFUNCTION, OXIDATIVE STRESS AND RISK OF PERIPHERAL ARTERIAL DISEASE | NIH | 2009 | 08-28-2009 | $ 1,006,905 |
| 071723621 | 1R01HL091998-01A2 | APOPTOSIS INDUCING FACTOR IN CARDIAC APOPTOSIS | NIH | 2009 | 05-29-2009 | $ 527,240 |
| 071723621 | 1R01HL094400-01 | PURINERGIC THROMBOREGULATION | NIH | 2009 | 05-29-2009 | $ 737,500 |
| 071723621 | 1R01NS061841-01A2 | NEURAL PATHWAY OF REM SLEEP ATONIA | NIH | 2009 | 09-03-2009 | $ 429,515 |
| 071723621 | 1R03HL095426-01A1 | ROLE OF INTERLEUKIN-17 AND INKT CELLS IN COPD | NIH | 2009 | 05-06-2009 | $ 86,458 |
| 071723621 | 1R21AA018204-01 | THE GEOGRAPHY OF VIOLENCE AND ALCOHOL IN BOSTON | NIH | 2009 | 05-05-2009 | $ 209,700 |
| 071723621 | 1R21DA026978-01 | NEURAL MECHANISMS OF THE METHAMPHETAMINE-SENSITIVE CIRCADIAN OSCILLATOR | NIH | 2009 | 06-03-2009 | $ 212,500 |
| 071723621 | 1R21DC009900-01A1 | ROLE OF CEREBRAL BLOOD FLOW IN NAUSEA AND MOTION SICKNESS | NIH | 2009 | 08-28-2009 | $ 254,242 |
| 071723621 | 1R21DK075857-01A2 | FIBROLYTIC ACTIVATION OF HEPATIC STELLATE CELLS BY T CELL DERIVED MICROPARTICLES | NIH | 2009 | 07-16-2009 | $ 212,500 |
| 071723621 | 1R21DK080970-01A2 | ORPHAN NUCLEAR RECEPTOR NUR77 AND INTESTINAL INFLAMMMATION | NIH | 2009 | 05-26-2009 | $ 255,000 |
| 071723621 | 1R21DK081773-01A1 | INVESTIGATION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DYSFUNCTION IN CHRONIC PELV | NIH | 2009 | 09-16-2009 | $ 5,300 |
| 071723621 | 1R21DK082987-01A1 | THE EFFECT OF DIABETES, NEUROPATHY AND ARTERIAL DISEASE IN LOWER EXTREMITY ENERGY | NIH | 2009 | 08-14-2009 | $ 253,761 |
| 071723621 | 1R21MH082235-01A1 | GABA AND EARLY INTERVENTION OF SCHIZOPHRENIA | NIH | 2009 | 07-15-2009 | $ 255,000 |
| 071723621 | 1R21NS065260-01 | INNATE IMMUNE MECHANISMS OF MOTOR NEURON INJURY | NIH | 2009 | 06-03-2009 | $ 255,000 |
| 071723621 | 1R21NS070295-01 | NEUROBIOLOGICAL MECHANISM OF 15Q11-13 DUPLICATION AUTISM SPECTRUM DISORDER | NIH | 2009 | 09-17-2009 | $ 303,625 |
| 071723621 | 1R56AI080779-01A1 | MODULATION OF INNATE IMMUNE CELLS TO CREATE TRANSPLANT TOLERANCE | NIH | 2010 | 08-23-2010 | $ 434,791 |
| 071723621 | 1RC1AR058389-01 | EFFECT OF PERINATAL DIET ON DEVELOPMENTAL PROGRAMMING OF THE SKELETON | NIH | 2009 | 09-28-2009 | $ 471,749 |
| 071723621 | 1RC1AR058776-01 | NOVEL, RAPIDLY TRANSLATABLE TECHNOLOGIES FOR HEALING LONG BONE SEGMENTAL DEFECTS | NIH | 2009 | 09-30-2009 | $ 500,000 |
| 071723621 | 1RC1CA145867-01 | TARGETING NON-HOMOLOGOUS END JOINING IN CANCER THERAPY | NIH | 2009 | 09-30-2009 | $ 502,557 |
| 071723621 | 1RC1CA146596-01 | EFFECTIVENESS OF EARLY STAGE PROSTATE CANCER TREATMENT | NIH | 2009 | 09-29-2009 | $ 499,994 |
| 071723621 | 1RC1DK087679-01 | NUCLEOPHOSMIN AND RIBOSOMAL DYSFUNCTION IN HEMATOLOGIC DISEASES | NIH | 2009 | 09-23-2009 | $ 500,000 |
| 071723621 | 1RC1EB011001-01 | EFFECTIVENESS OF ROBOTIC COMPARED TO STANDARD PROSTATECTOMY FOR PROSTATE CANCER | NIH | 2009 | 09-22-2009 | $ 500,000 |
| 071723621 | 1RC1HL099749-01 | ECG-DERIVED CARDIOPULMONARY COUPLING BIOMARKERS OF SLEEP, SLEEP-BREATHING, AND CA | NIH | 2009 | 09-23-2009 | $ 500,000 |
| 071723621 | 1RC1HL100110-01 | DETERMINANTS OF DISEASE EXPRESSION IN ARRHYTHMOGENIC CARDIOMYOPATHY | NIH | 2009 | 09-18-2009 | $ 499,984 |
| 071723621 | 1RC2CA147940-01 | THE CO-CLINICAL PROJECT: INFORMING CLINICAL TRIALS USING PRECLINICAL MOUSE MODELS | NIH | 2009 | 09-30-2009 | $ 2,064,367 |
| 071723621 | 2R01AI057409-06 | MECHANISMS MEDIATING CD28 AND CD154 INDEPENDENT REJECTION | NIH | 2009 | 08-28-2009 | $ 303,114 |
| 071723621 | 2R01CA041456-24 | MOLECULAR BIOLOGY OF HUMAN MYELOID DIFFERENTIATION | NIH | 2009 | 07-14-2009 | $ 425,000 |
| 071723621 | 2R01DK060673-06A2 | REGULATION OF HYPOTHALAMIC POMC BY LEPTIN | NIH | 2009 | 07-16-2009 | $ 431,563 |
| 071723621 | 2R01DK062307-06A2 | ATROGIN-1 AND MUSCLE PROTEIN BALANCE | NIH | 2009 | 09-17-2009 | $ 325,001 |
| 071723621 | 2R01HL029077-26A2 | MYOCARDIAL PROTECTION: REPERFUSION INJURY AMELIORATION | NIH | 2009 | 08-12-2009 | $ 465,419 |
| 071723621 | 2R01HL049081-15A1 | THROMBOSPONDIN 4 A1 | NIH | 2009 | 05-29-2009 | $ 711,148 |
| 071723621 | 2R01HL080192-06 | TUMOR SELECTIVE APOPTOSIS BY TRAIL | NIH | 2009 | 09-09-2009 | $ 646,990 |
| 071723621 | 3K08DK076868-03S1 | ENTPD1: A CANDIDATE SUSCEPTIBILITY GENE FOR RENOVASCULAR DISEASE | NIH | 2010 | 12-17-2009 | $ 54,000 |
| 071723621 | 3P01DK080665-02S1 | HEMATOPOIETIC STEM CELL COMMITMENT | NIH | 2009 | 09-22-2009 | $ 250,000 |
| 071723621 | 3P01DK080665-02S2 | HEMATOPOIETIC STEM CELL COMMITMENT | NIH | 2010 | 12-21-2009 | $ 0 |
| 071723621 | 3P50MH080272-03S2 | VULNERABILITY TO PROGRESSION SCHIZOPHRENIA | NIH | 2009 | 09-29-2009 | $ 305,041 |
| 071723621 | 3R00CA126026-03S1 | ROLE OF EGFR MUTATIONS AND NEW THERAPEUTICS IN LUNG CANCER | NIH | 2009 | 09-30-2009 | $ 85,141 |
| 071723621 | 3R01AG019787-08S1 | SOMATIC MTDNA MUTATIONS IN BRAIN AGING: A SINGLE-CELL APPROACH | NIH | 2009 | 09-29-2009 | $ 368,869 |
| 071723621 | 3R01AG022082-05S1 | PROLYL ISOMERASE PIN 1 AND NEURODEGENERATION | NIH | 2009 | 09-16-2009 | $ 166,618 |
| 071723621 | 3R01AI020241-25S1 | HUMAN EOSINOPHILS: MECHANISMS OF FUNCTIONING | NIH | 2009 | 07-13-2009 | $ 19,720 |
| 071723621 | 3R01AI051645-07S1 | AIRWAYS EOSINOPHILS AS ANTIGEN-PRESENTING CELLS IN ASTHMA | NIH | 2009 | 09-14-2009 | $ 291,191 |
| 071723621 | 3R01AI063571-05S1 | FORMINS (FHOS) IN CD21-MEDIATED SIGNALING & VIRUS ENTRY | NIH | 2009 | 06-03-2009 | $ 39,440 |
| 071723621 | 3R01AR042773-11S1 | MULTIPARAMETRIC MRI OF CARTILAGE | NIH | 2009 | 06-08-2009 | $ 10,945 |
| 071723621 | 3R01CA125550-02S3 | ROLE OF FIBROBLASTS IN CANCER | NIH | 2009 | 09-30-2009 | $ 194,600 |
| 071723621 | 3R01DC008796-02S1 | BEHAVIORAL AND NEURAL CORRELATES OF MELODIC INTONATION THERAPY | NIH | 2009 | 07-15-2009 | $ 180,175 |
| 071723621 | 3R01DK037908-19S1 | MUSCLE PROTEIN TURNOVER AND AMINO ACID UPTAKE IN SEPSIS | NIH | 2010 | 12-21-2009 | $ 164,524 |
| 071723621 | 3R01DK058785-07S1 | ROLE OF LEPTIN IN THE NEUROENDOCRINE RESPONSE TO FASTING | NIH | 2010 | 12-03-2009 | $ 100,000 |
| 071723621 | 3R01DK058785-08S1 | ROLE OF LEPTIN IN THE NEUROENDOCRINE RESPONSE TO FASTING | NIH | 2010 | 04-05-2010 | $ 102,060 |
| 071723621 | 3R01DK059588-11S1 | BIOLOGICAL MECHANISM OF FSGS-1 | NIH | 2011 | 02-11-2011 | $ 52,836 |
| 071723621 | 3R01DK069983-04S1 | ACTIONS OF MELANIN CONCENTRATING HORMONE IN THE BRAIN | NIH | 2010 | 12-18-2009 | $ 80,700 |
| 071723621 | 3R01DK073302-03S1 | UNDERSTANDING HOW PATIENTS VALUE BARIATRIC SURGERY | NIH | 2009 | 07-30-2009 | $ 88,164 |
| 071723621 | 3R01DK076937-04S1 | IMPAIRED WOUND HEALING IN DIABETIC FOOT ULCERATION | NIH | 2010 | 01-01-2010 | $ 10,000 |
| 071723621 | 3R01DK078090-03S1 | NEGATIVE REGULATION BY THYROID HORMONE | NIH | 2010 | 01-26-2010 | $ 50,930 |
| 071723621 | 3R01DK079665-03S1 | A RANDOMIZED TRIAL AND REDUCE TO DISPARITY IN LIVE DONOR KIDNEY TRANSPLANTATION | NIH | 2010 | 05-28-2010 | $ 147,247 |
| 071723621 | 3R01GM058556-11S1 | FUNCTION AND REGULATION OF THE PHOSPHORYLATION-SPECIFIC PROLYL LSOMERASE PIN 1 | NIH | 2010 | 12-04-2009 | $ 149,361 |
| 071723621 | 3R01GM073911-04S1 | PROMOTER PREDICTION USING THE OPENING PROFILE OF DNA | NIH | 2009 | 09-09-2009 | $ 121,536 |
| 071723621 | 3R01HL080192-05S1 | TUMOR SELECTIVE APOPTOSIS BY TRAIL | NIH | 2009 | 07-30-2009 | $ 266,055 |
| 071723621 | 3R01HL080699-05S1 | HIV-1 GP120-MEDIATED INJURY IN BRAIN ENDOTHELIUM | NIH | 2009 | 05-29-2009 | $ 50,510 |
| 071723621 | 3R01HL082837-03S1 | THE ROLE OF RTEF-1 IN ANGIOGENESIS AND MYOCARDIAL ISCHEMIA | NIH | 2009 | 07-15-2009 | $ 324,161 |
| 071723621 | 3R01HL084331-02S1 | CT DIAGNOSIS OF TRACHEOMALACIA IN PATIENTS WITH COPD | NIH | 2009 | 07-20-2009 | $ 173,409 |
| 071723621 | 3R01HL091757-01A1S1 | ENDOTHELIAL CELL SIGNALING AND MICROCIRCULATORY FLOW IN SEVERE SEPSIS | NIH | 2009 | 07-15-2009 | $ 345,523 |
| 071723621 | 3R01HL093234-01S1 | ANGIOPOIETIN MECHANISMS IN SEPSIS | NIH | 2009 | 07-30-2009 | $ 294,255 |
| 071723621 | 3R01NS033987-13S1 | NEURONAL MECHANISMS OF FEVER | NIH | 2009 | 09-28-2009 | $ 121,764 |
| 071723621 | 3R01NS047029-05A1S1 | ROLE OF INFLAMMATION IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | NIH | 2009 | 08-19-2009 | $ 156,225 |
| 071723621 | 3R01NS051446-03S1 | USING TMS TO ENHANCE OFF-LINE LEARNING. | NIH | 2009 | 08-11-2009 | $ 80,744 |
| 071723621 | 3R01NS061863-01A1S1 | PONTINE CONTROL OF REM ATONIA | NIH | 2009 | 07-20-2009 | $ 11,001 |
| 071723621 | 3R01NS061863-01A1S3 | PONTINE CONTROL OF REM ATONIA | NIH | 2009 | 08-17-2009 | $ 110,013 |
| 071723621 | 3R03ES017125-01A1S1 | AMBIENT PARTICLES AND ISCHEMIC AND HEMORRHAGIC STROKE | NIH | 2009 | 07-10-2009 | $ 25,265 |
| 071723621 | 3R24RR016001-09S1 | RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES | NIH | 2009 | 09-16-2009 | $ 376,171 |
| 071723621 | 3R24RR016001-10S1 | RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES | NIH | 2010 | 08-12-2010 | $ 347,988 |
| 071723621 | 3R37DK043051-18S1 | GLUCOSE TRANSPORTER REGULATION IN OBESITY AND DIABETES | NIH | 2009 | 09-29-2009 | $ 575,217 |
| 071723621 | 3R37DK043051-18S2 | GLUCOSE TRANSPORTER REGULATION IN OBESITY AND DIABETES | NIH | 2010 | 12-30-2009 | $ 100,000 |
| 071723621 | 3R37DK053477-12S1 | GLUCOSE-SENSING BY NEURONS: ITS IMPORTANCE AND THE ROLE OF UCP2 | NIH | 2009 | 09-28-2009 | $ 361,129 |
| 071723621 | 3R37DK053477-12S2 | GLUCOSE-SENSING BY NEURONS: ITS IMPORTANCE AND THE ROLE OF UCP2 | NIH | 2010 | 12-18-2009 | $ 202,131 |
| 071723621 | 3U01AI066331-05S1 | THROMBOREGULATORY STRATEGIES TO PROLONG XENOGRAFT SURVIVAL. | NIH | 2009 | 08-28-2009 | $ 982,867 |
| 071723621 | 3U19AI078526-02S1 | NOVEL HETEROLOGOUS ADENOVIRUS PRIME-BOOST HIV-1 VACCINE | NIH | 2009 | 08-28-2009 | $ 1,620,774 |
| 071723621 | 5F32AI081513-02 | TETRASPANINS IN ASTHMA AND EOSINOPHILIC LUNG DISEASE | NIH | 2010 | 06-25-2010 | $ 59,918 |
| 071723621 | 5R01AG028076-02 | CEREBROMICROVASCULAR DISEASE IN ELDERLY WITH DIABETES | NIH | 2010 | 07-19-2010 | $ 592,598 |
| 071723621 | 5R01AI057409-07 | MECHANISMS MEDIATING CD28 AND CD154 INDEPENDENT REJECTION | NIH | 2010 | 08-12-2010 | $ 303,625 |
| 071723621 | 5R01AI072287-02 | AUTOCRINE CONTROL OF NEUTROPHIL CHEMOTAXIS | NIH | 2010 | 04-28-2010 | $ 383,000 |
| 071723621 | 5R01AI075129-02 | STORE OPERATED CALCIUM INFLUX IN CELLS OF THE IMMUNE SYSTEM | NIH | 2010 | 06-16-2010 | $ 425,000 |
| 071723621 | 5R01CA041456-25 | MOLECULAR BIOLOGY OF HUMAN MYELOID DIFFERENTIATION | NIH | 2010 | 05-21-2010 | $ 425,000 |
| 071723621 | 5R01CA130895-02 | INHIBITION OF ANGIOGENESIS BY THROMBOSPONDIN-1 (A2) | NIH | 2010 | 05-10-2010 | $ 363,727 |
| 071723621 | 5R01CA142262-02 | VEGFS IN TUMOR LYMPHATIC METASTASIS | NIH | 2010 | 06-22-2010 | $ 473,057 |
| 071723621 | 5R01DK060673-07 | REGULATION OF HYPOTHALAMIC POMC BY LEPTIN | NIH | 2010 | 07-01-2010 | $ 434,688 |
| 071723621 | 5R01DK062307-07 | ATROGIN-1 AND MUSCLE PROTEIN BALANCE | NIH | 2010 | 08-30-2010 | $ 331,694 |
| 071723621 | 5R01GM088184-02 | ROLE OF VEGF AND PLGF SIGNALING IN SEPSIS | NIH | 2010 | 09-01-2010 | $ 375,750 |
| 071723621 | 5R01HL029077-27 | MYOCARDIAL PROTECTION: REPERFUSION INJURY AMELIORATION | NIH | 2010 | 08-06-2010 | $ 470,821 |
| 071723621 | 5R01HL049081-16 | THROMBOSPONDIN 4 A1 | NIH | 2010 | 07-20-2010 | $ 701,914 |
| 071723621 | 5R01HL080192-07 | TUMOR SELECTIVE APOPTOSIS BY TRAIL | NIH | 2010 | 08-23-2010 | $ 632,013 |
| 071723621 | 5R01HL091874-02 | ENDOTHELIAL DYSFUNCTION, OXIDATIVE STRESS AND RISK OF PERIPHERAL ARTERIAL DISEASE | NIH | 2010 | 08-05-2010 | $ 960,414 |
| 071723621 | 5R01HL091998-02 | APOPTOSIS INDUCING FACTOR IN CARDIAC APOPTOSIS | NIH | 2010 | 05-25-2010 | $ 529,912 |
| 071723621 | 5R01HL094400-02 | PURINERGIC THROMBOREGULATION | NIH | 2010 | 07-20-2010 | $ 637,500 |
| 071723621 | 5R01NS061841-02 | NEURAL PATHWAY OF REM SLEEP ATONIA | NIH | 2010 | 08-10-2010 | $ 426,920 |
| 071723621 | 5R03HL095426-02 | ROLE OF INTERLEUKIN-17 AND INKT CELLS IN COPD | NIH | 2010 | 07-28-2010 | $ 86,959 |
| 071723621 | 5R21AA018204-02 | THE GEOGRAPHY OF VIOLENCE AND ALCOHOL IN BOSTON | NIH | 2010 | 06-02-2010 | $ 255,000 |
| 071723621 | 5R21DA026978-02 | NEURAL MECHANISMS OF THE METHAMPHETAMINE-SENSITIVE CIRCADIAN OSCILLATOR | NIH | 2010 | 06-02-2010 | $ 255,000 |
| 071723621 | 5R21DK075857-02 | FIBROLYTIC ACTIVATION OF HEPATIC STELLATE CELLS BY T CELL DERIVED MICROPARTICLES | NIH | 2010 | 05-26-2010 | $ 255,000 |
| 071723621 | 5R21DK080970-02 | ORPHAN NUCLEAR RECEPTOR NUR77 AND INTESTINAL INFLAMMMATION | NIH | 2010 | 06-30-2010 | $ 212,500 |
| 071723621 | 5R21DK082987-02 | THE EFFECT OF DIABETES, NEUROPATHY AND ARTERIAL DISEASE IN LOWER EXTREMITY ENERGY | NIH | 2010 | 08-09-2010 | $ 198,639 |
| 071723621 | 5R21MH082235-02 | GABA AND EARLY INTERVENTION OF SCHIZOPHRENIA | NIH | 2010 | 08-03-2010 | $ 212,500 |
| 071723621 | 5R21NS065260-02 | INNATE IMMUNE MECHANISMS OF MOTOR NEURON INJURY | NIH | 2010 | 05-06-2010 | $ 212,500 |
| 071723621 | 5R21NS070295-02 | NEUROBIOLOGICAL MECHANISM OF 15Q11-13 DUPLICATION AUTISM SPECTRUM DISORDER | NIH | 2010 | 08-13-2010 | $ 304,500 |
| 071723621 | 5RC1AR058389-02 | EFFECT OF PERINATAL DIET ON DEVELOPMENTAL PROGRAMMING OF THE SKELETON | NIH | 2010 | 08-17-2010 | $ 483,526 |
| 071723621 | 5RC1AR058776-02 | NOVEL, RAPIDLY TRANSLATABLE TECHNOLOGIES FOR HEALING LONG BONE SEGMENTAL DEFECTS | NIH | 2010 | 08-17-2010 | $ 480,186 |
| 071723621 | 5RC1CA145867-02 | TARGETING NON-HOMOLOGOUS END JOINING IN CANCER THERAPY | NIH | 2010 | 08-18-2010 | $ 497,443 |
| 071723621 | 5RC1CA146596-02 | EFFECTIVENESS OF EARLY STAGE PROSTATE CANCER TREATMENT | NIH | 2010 | 08-27-2010 | $ 496,220 |
| 071723621 | 5RC1DK087679-02 | NUCLEOPHOSMIN AND RIBOSOMAL DYSFUNCTION IN HEMATOLOGIC DISEASES | NIH | 2010 | 09-06-2010 | $ 500,000 |
| 071723621 | 5RC1EB011001-02 | EFFECTIVENESS OF ROBOTIC COMPARED TO STANDARD PROSTATECTOMY FOR PROSTATE CANCER | NIH | 2010 | 08-10-2010 | $ 500,000 |
| 071723621 | 5RC1HL099749-02 | ECG-DERIVED CARDIOPULMONARY COUPLING BIOMARKERS OF SLEEP, SLEEP-BREATHING, AND CA | NIH | 2010 | 08-20-2010 | $ 500,000 |
| 071723621 | 5RC1HL100110-02 | DETERMINANTS OF DISEASE EXPRESSION IN ARRHYTHMOGENIC CARDIOMYOPATHY | NIH | 2010 | 08-10-2010 | $ 475,667 |
| 071723621 | 5RC2CA147940-02 | THE CO-CLINICAL PROJECT: INFORMING CLINICAL TRIALS USING PRECLINICAL MOUSE MODELS | NIH | 2010 | 09-07-2010 | $ 2,088,292 |
| 071723621 | K08DK080947-3-004 | TRPC6 REGULATION AND ITS ROLE IN GLOMERULAR PATHOLOGY | NIH | 2010 | 09-23-2010 | $ 48,154 |
| 071723621 | P01AI041521-14-003 | COSTIMULATION AND CYTOKINES IN TOLERANCE | NIH | 2010 | 08-24-2010 | $ 135,986 |
| 071723621 | R21AA018204-2-000 | THE GEOGRAPHY OF VIOLENCE AND ALCOHOL IN BOSTON | NIH | 2012 | 03-13-2012 | $- 196,976 |
| 071723621 | R21DC009900-1-001 | ROLE OF CEREBRAL BLOOD FLOW IN NAUSEA AND MOTION SICKNESS | NIH | 2010 | 02-04-2010 | $- 254,242 |
To continue, click on the Award Title in the list above to obtain detailed data about a specific Award.
The Award Detail screen should display with the data for that award that is available for reporting to FederalReporting.gov.
DISCLAIMER
The data contained in the HHS Recipient Readiness Tool reflects the best available data for HHS grant programs that are subject to Recovery Act Recipient Reporting. Please note that according to OMB supplemental guidance recipients are not required to report on awards less than $25,000 on FederalReporting.gov. For a list of programs that must be reported to FederalReporting.gov please visit Appendix 1 of the June 22nd OMB guidance. For additional questions or concerns on reporting requirements for your award please contact your grants management specialist.
Data are refreshed every 24 hours. Awards issued near the end of the reporting period may not be available for 72 hours pending the timeliness of HHS Agency data transmission. If you are unable to locate your data please contact your grants management specialist.
